Apollomics (APLM) Short Interest Ratio & Short Volume $0.15 -0.01 (-6.26%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Apollomics Short Interest DataApollomics (APLM) has a short interest of 168,500 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -49.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2.32 million shares to cover all short positions.Current Short Interest168,500 sharesPrevious Short Interest333,700 sharesChange Vs. Previous Month-49.51%Dollar Volume Sold Short$20,034.65Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares108,660,000 sharesFloat Size66,390,000 sharesShort Percent of Float0.25%Today's Trading Volume9,491,217 sharesAverage Trading Volume2,318,414 sharesToday's Volume Vs. Average409% Short Selling Apollomics? Sign up to receive the latest short interest report for Apollomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPLM Short Interest Over TimeAPLM Days to Cover Over TimeAPLM Percentage of Float Shorted Over Time Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Apollomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024168,500 shares $20,034.65 -49.5%0.3%0 $0.12 10/15/2024333,700 shares $41,745.87 +32.7%0.5%0.1 $0.13 9/30/2024251,400 shares $35,749.08 -52.0%0.4%0.1 $0.14 9/15/2024523,200 shares $71,155.20 -6.7%0.8%0.1 $0.14 8/31/2024561,000 shares $67,376.10 -79.9%0.9%0.1 $0.12 8/15/20242,790,000 shares $412,920.00 +607.1%4.2%0.7 $0.15 Get the Latest News and Ratings for APLM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024394,600 shares $74,974.00 +637.6%0.7%0.4 $0.19 7/15/202453,500 shares $10,619.75 -69.8%0.1%0.1 $0.20 6/30/2024177,100 shares $37,350.39 +120.8%0.3%0.5 $0.21 6/15/202480,200 shares $16,120.20 -44.6%0.2%0.2 $0.20 5/31/2024144,700 shares $43,120.60 +76.7%0.3%0.4 $0.30 5/15/202481,900 shares $28,116.27 -32.6%0.2%0.4 $0.34 4/30/2024121,500 shares $51,759.00 -42.0%0.2%0.6 $0.43 4/15/2024209,300 shares $117,208.00 +35.0%0.3%1.1 $0.56 3/31/2024155,100 shares $116,325.00 +238.7%0.2%0.7 $0.75 3/15/202445,800 shares $27,525.80 +4.3%0.1%0.2 $0.60 2/29/202443,900 shares $32,881.10 +121.7%0.1%0.2 $0.75 2/15/202419,800 shares $13,135.32 -69.0%0.0%0 $0.66 1/31/202463,900 shares $51,759.00 -54.5%0.1%0 $0.81 1/15/2024140,500 shares $138,954.50 -4.8%2.7%0 $0.99 12/31/2023147,600 shares $142,434.00 +87.3%2.8%0 $0.97 12/15/202378,800 shares $62,015.60 -82.8%1.5%0 $0.79 11/30/2023457,900 shares $432,715.50 +100.8%8.8%0.1 $0.95 11/15/2023228,100 shares $198,447.00 -82.5%4.4%0.1 $0.87 10/31/20231,300,000 shares $1.04 million +39,293.9%27.8%0.8 $0.80 10/15/20233,300 shares $6,633.00 -26.7%0.1%0.1 $2.01 9/30/20234,500 shares $16,852.50 +36.4%0.1%0.3 $3.75 9/15/20233,300 shares $12,903.00 -19.5%0.1%0.2 $3.91 8/31/20234,100 shares $19,577.50 +57.7%0.1%0.2 $4.78 8/15/20232,600 shares $13,676.00 -74.5%0.1%0 $5.26 7/31/202310,200 shares $55,284.00 -48.2%0.2%0.1 $5.42 7/15/202319,700 shares $110,123.00 -56.3%0.4%0.1 $5.59 6/30/202345,100 shares $258,423.00 -40.1%0.9%0.3 $5.73 6/15/202375,300 shares $354,663.00 -6.3%1.4%0.4 $4.71 5/31/202380,400 shares $325,620.00 +2.3%1.5%0.4 $4.05 5/15/202378,600 shares $343,482.00 No Change1.7%0.5 $4.37 APLM Short Interest - Frequently Asked Questions What is Apollomics' current short interest? Short interest is the volume of Apollomics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 168,500 shares of APLM short. 0.25% of Apollomics' shares are currently sold short. Learn More on Apollomics' current short interest. What is a good short interest percentage for Apollomics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of Apollomics' floating shares are currently sold short. Is Apollomics' short interest increasing or decreasing? Apollomics saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 168,500 shares, a decline of 49.5% from the previous total of 333,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Apollomics' float size? Apollomics currently has issued a total of 108,660,000 shares. Some of Apollomics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apollomics currently has a public float of 66,390,000 shares. How does Apollomics' short interest compare to its competitors? 0.25% of Apollomics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Apollomics: CytomX Therapeutics, Inc. (7.25%), Leap Therapeutics, Inc. (3.54%), BeyondSpring Inc. (8.34%), Cellectar Biosciences, Inc. (4.69%), Celularity Inc. (6.92%), ALX Oncology Holdings Inc. (25.91%), Immuneering Co. (9.76%), Spero Therapeutics, Inc. (1.15%), InterCure Ltd. (0.05%), CervoMed Inc. (27.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Apollomics stock? Short selling APLM is an investing strategy that aims to generate trading profit from Apollomics as its price is falling. APLM shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Apollomics? A short squeeze for Apollomics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APLM, which in turn drives the price of the stock up even further. How often is Apollomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLM, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CytomX Therapeutics Short Squeeze Leap Therapeutics Short Squeeze BeyondSpring Short Squeeze Cellectar Biosciences Short Squeeze Celularity Short Squeeze ALX Oncology Short Squeeze Immuneering Short Squeeze Spero Therapeutics Short Squeeze InterCure Short Squeeze CervoMed Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APLM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.